People Jurgen Futterer MRI-guided Transurethral UltraSound Ablation

MRI-guided Transurethral UltraSound Ablation

We perform MRI-guided Transurethral UltraSound Ablation (TULSA) in the prostate.

Jurgen Futterer MD PhD

full professor

+31 (0)24 361 40 11
read more

Aims

We perform MRI-guided Transurethral UltraSound Ablation (TULSA) in patients with localized prostate cancer.

read more

Aims

We perform MRI-guided Transurethral UltraSound Ablation (TULSA) in patients with localized prostate cancer. We can either treat the whole prostate or only a specific area of the prostate. The ablation device is inserted in the patient’s urethra. During ablation high-intensity ultrasound waves will destroy the prostate tissue. The ablation process is continuously monitored by real-time MR temperature mapping. A special balloon is inserted in the rectum to cool the rectal wall and to prevent it from heating.
 

Research within MITeC

The TULSA treatment is performed at the MITeC facility, under real-time MRI guidance. So, during the treatment, the patient is in the MR-scanner.

Collaboration partner(s)

Team

Radboud Institute for Health Sciences

Ideally, every procedure in clinical practice and public health should take place based on proof, instead of intuition or 'experience'. Our aim is to innovate and personalize healthcare and public health. read more

MITeC Connected operating rooms, for advancing innovation in patient care

MITeC offers unique consulting services and expertise to incorporate newly developed medical technology innovations and accelerate their success rate.

read more